Jayoung Kim1, Adam C Mirando2, Aleksander S Popel2, Jordan J Green3. 1. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Translational Tissue Engineering Center and Institute for Nanobiotechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. 2. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. 3. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Translational Tissue Engineering Center and Institute for Nanobiotechnology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Departments of Ophthalmology, Neurosurgery, and Materials Science & Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. Electronic address: green@jhu.edu.
Abstract
Angiogenesis is naturally balanced by many pro- and anti-angiogenic factors while an imbalance of these factors leads to aberrant angiogenesis, which is closely associated with many diseases. Gene therapy has become a promising strategy for the treatment of such a disordered state through the introduction of exogenous nucleic acids that express or silence the target agents, thereby engineering neovascularization in both directions. Numerous non-viral gene delivery nanoparticles have been investigated towards this goal, but their clinical translation has been hampered by issues associated with safety, delivery efficiency, and therapeutic effect. This review summarizes key factors targeted for therapeutic angiogenesis and anti-angiogenesis gene therapy, non-viral nanoparticle-mediated approaches to gene delivery, and recent gene therapy applications in pre-clinical and clinical trials for ischemia, tissue regeneration, cancer, and wet age-related macular degeneration. Enhanced nanoparticle design strategies are also proposed to further improve the efficacy of gene delivery nanoparticles to modulate angiogenesis.
Angiogenesis is naturally balanced by many pro- and anti-angiogenic factors while an imbalance of these factors leads to aberrant angiogenesis, which is closely associated with many diseases. Gene therapy has become a promising strategy for the treatment of such a n>an class="Disease">disordered state through the introduction of exogenous nucleic acids that express or silence the target agents, thereby engineering neovascularization in both directions. Numerous non-viral gene delivery nanoparticles have been investigated towards this goal, but their clinical translation has been hampered by issues associated with safety, delivery efficiency, and therapeutic effect. This review summarizes key factors targeted for therapeutic angiogenesis and anti-angiogenesis gene therapy, non-viral nanoparticle-mediated approaches to gene delivery, and recent gene therapy applications in pre-clinical and clinical trials for ischemia, tissue regeneration, cancer, and wet age-related macular degeneration. Enhanced nanoparticle design strategies are also proposed to further improve the efficacy of gene delivery nanoparticles to modulate angiogenesis.
Authors: Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite Journal: J Am Coll Cardiol Date: 2005-11-09 Impact factor: 24.094
Authors: Eckehard Gerd Kilian; Sebastian Sadoni; Calin Vicol; Ralph Kelly; Karen van Hulst; Markus Schwaiger; Christian Kupatt; Peter Boekstegers; Ravi Pillai; Keith Channon; Roland Hetzer; Bruno Reichart Journal: Circ J Date: 2010-03-10 Impact factor: 2.993
Authors: Eric M Bressler; Jayoung Kim; Ron B Shmueli; Adam C Mirando; Hojjat Bazzazi; Esak Lee; Aleksander S Popel; Niranjan B Pandey; Jordan J Green Journal: J Biomed Mater Res A Date: 2018-02-23 Impact factor: 4.396
Authors: Jayoung Kim; Raquel Lima E Silva; Ron B Shmueli; Adam C Mirando; Stephany Y Tzeng; Niranjan B Pandey; Elana Ben-Akiva; Aleksander S Popel; Peter A Campochiaro; Jordan J Green Journal: Acta Biomater Date: 2019-07-30 Impact factor: 8.947
Authors: Mariana Barreto Serra; Wermerson Assunção Barroso; Neemias Neves da Silva; Selma do Nascimento Silva; Antonio Carlos Romão Borges; Iracelle Carvalho Abreu; Marilene Oliveira da Rocha Borges Journal: Int J Inflam Date: 2017-07-25
Authors: Juan L Paris; Filipe Coelho; Alexandra Teixeira; Lorena Diéguez; Bruno F B Silva; Sara Abalde-Cela Journal: Molecules Date: 2020-07-18 Impact factor: 4.411
Authors: Dilara Z Gatina; Ekaterina E Garanina; Margarita N Zhuravleva; Gulnaz E Synbulatova; Adelya F Mullakhmetova; Valeriya V Solovyeva; Andrey P Kiyasov; Catrin S Rutland; Albert A Rizvanov; Ilnur I Salafutdinov Journal: Int J Mol Sci Date: 2021-05-31 Impact factor: 5.923